Gesundes Kinzigtal improves contribution margin

For the seventh consecutive year, Gesundes Kinzigtal was able to improve its contribution margin. In 2013 this amounted to Euro 5.5 million for the 33,000 members of the two partner insurance funds, AOK Baden-Württemberg and Landwirtschaftliche Krankenkasse (LKK). On average, every member costs Euro 170 less than the national average. The improvement in the contribution margin can be ascribed to the difference between the expected costs (Euro 75.5 million) and the actual cost of members in Kinzigtal. The entire population of the two health insurance companies is used when calculating the contribution amount. Gesundes Kinzigtal achieved these positive effects in Kinzigtal because members have been empowered and enabled to promote and maintain their health. A key success factor is that the intervention focuses on the health of the population, while clubs, municipalities and businesses are also involved. In this way, instruments such as coaching and case management make possible healthcare which is not only economically, but also qualitatively, good. In Kinzigtal, improving the economy goes hand in hand with high quality of healthcare for the policyholder community. This is confirmed by the latest evaluation by the PMV Research Institute of the University of Cologne.

Good Process Quality in Drug Therapy

The Cologne researchers have been appointed by the three partners – Gesundes Kinzigtal and both insurances – to regularly evaluate Integrated Healthcare on the basis of routine administrative data. For this reason, possible overuse, underuse or misuse in the Kinzigtal population, are analyzed and compared to a control group from Baden-Wuerttemberg. In their current evaluation the researchers have come to the conclusion that in Kinzigtal prescription extent and duration for drugs with addiction potential as sedatives or drugs with the potential to develop resistance, such as antibiotics, are lower than in the Baden-Württemberg control group. This decrease of overuse is considered a positive indicator for the quality of care, since the likelihood of adverse side effects is reduced. On the other hand, there has been a continuous increase in recommended medication guidelines, of, for example, platelet aggregation inhibitors or beta-blockers in Kinzigtal since the beginning of the intervention. For the researchers, this confirms the reduction of undertreatment. Old people, too, are benefiting from drug therapy in Kinzigtal. They are particularly vulnerable to the adverse and reciprocal effects of drugs, especially when taking multiple medications simultaneously. Thus, the Cologne researchers have also studied the prescription rate of potentially inappropriate drugs for the elderly. Here, the Kinzigtal samples also did better than the control group. The external evaluation confirms the quality of drug therapy in Kinzigtal and illustrates the reduction of over- and undertreatment in selected indications, emphasize the initiators of Gesundes Kinzigtal.